Lithium in the prophylaxis of depressive illness in late life

  • Karabi Ghose
  • Alec Coppen


Depression is one of the most common symptoms presented by the elderly (Kantor and Glassman, 1980). Depressive illness is a recurrent condition in 60% of cases and usually presents for the first time in the 40s. Depression in the older age group consists of patients whose illness arose earlier in life and persists until the older ages, and patients in whom depression presents for the first time in late life after 70.


Affective Disorder Late Life Unipolar Depression Depressive Illness Prophylactic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abou-Saleh, M.T. and Coppen, A. (1983). Subjective side-effects of amitriptyline and lithium in affective disorders. Br. J. Psychiat., 142, 527–8.CrossRefGoogle Scholar
  2. Abou-Saleh, M.T. and Coppen, A. (1983b) Classification of depression and response to antidepressive therapies. Br. J. Psychiat., 143, 601–3.CrossRefGoogle Scholar
  3. Angst, J., Weis, P. and Grof, P. (1970) Lithium prophylaxis in recurrent affective disorders. Br. J. Psychiat., 116, 604–14.CrossRefGoogle Scholar
  4. Angst, J. (1981) Clinical indications for a prophylactic treatment of depression. Adv. Biol. Psychiat., 7, 218–29.Google Scholar
  5. Baastrup, P. and Schou, M. (1967) Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch. Gen. Psychiat., 16, 162–72.CrossRefPubMedGoogle Scholar
  6. Baastrup, P., Poulsen, J.C. and Schou, M. (1970) Prophylactic lithium. Double-blind discontinuation in manic depressive and recurrent depressive disorders. Lancet, ii, 326–30.CrossRefGoogle Scholar
  7. Carney, M.H.P., Roth, M. and Garside, R.F. (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br. J. Psychiat., 111, 659–74.CrossRefGoogle Scholar
  8. Coppen, A. and Abou-Saleh, M.T. (1983) Lithium in the prophylaxis of unipolar depression. J. Roy. Soc. Med., 76, 297–301.PubMedGoogle Scholar
  9. Coppen, A., Abou-Saleh, M.T., Milln, P. et al. (1981) Lithium continuation therapy following ECT. Br. J. Psychiat., 139, 284–7.CrossRefGoogle Scholar
  10. Coppen, A., Abou-Saleh, M.T., Milln, P. et al. (1983) Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. J. Affect. Disord., 5, 353–62.CrossRefPubMedGoogle Scholar
  11. Coppen, A., Chaudhury, S. and Swade, C. (1986) Folic acid enhances lithium prophylaxis. J. Affect. Disord., 10, 9–13.CrossRefPubMedGoogle Scholar
  12. Coppen, A., Ghose, K., Montgomery, S. et al. (1978a) Continuation therapy with amitriptyline in depression. Brit. J. Psychiat., 133, 28–33.CrossRefPubMedGoogle Scholar
  13. Coppen, A., Ghose, K., Rao, V.A.R. et al. (1978b) Mianserin and lithium in the prophylaxis of depression. Br. J. Psychiat., 133, 206–10.CrossRefGoogle Scholar
  14. Coppen, A., Metcalfe, M. and Bailey, J. (1979) Lithium prophylactic therapy in unipolar depression and some possible prognostigators of response. In: Lithium Controversies and Unresolved Issues (eds. T.B. Cooper, S. Gershon, N.S. Kline and M. Scholl), Excerpta Medica, Amsterdam, pp. 401–12.Google Scholar
  15. Coppen, A., Montgomery, S.A., Gupta, R.K. and Bailey, J. (1976) A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of affective disorders. Br. J. Psychiat., 128, 479–85.CrossRefGoogle Scholar
  16. Coppen, A., Noguera, R., Bailey, J. et al. (1971) Prophylactic lithium in affective disorders — controlled trial. Lancet, ii, 275–9.CrossRefGoogle Scholar
  17. Eysenck, H.J. and Eysenck, S.B.G. (1964) Manual of Eysenck Personality Inventory, University of London Press, London.Google Scholar
  18. Fieve, R.R., Dunner, D.L. and Kumbarachi, T. (1975) Lithium carbonate in affective disorders. Arch. Gen. Psychiat., 32, 1541–4.CrossRefPubMedGoogle Scholar
  19. Ghose, K. (1977) Lithium salts: therapeutic and unwanted effects. Br. J. Hosp. Med., 18, 578–83.PubMedGoogle Scholar
  20. Glen, A. (1981) Lithium and antidepressants in the prophylaxis of depression. Adv. Biol Pyschiat., 7, 208–17.Google Scholar
  21. Greenblatt, D.J., Divoli, M., Abernethy, D.R. and Shader, R.I. (1982) Physiologic change in old age: relation to altered drug disposition. J. Am. Geriat. Soc., 30, (Suppl.) S6–S10.Google Scholar
  22. Hullin, R.P., McDonald, R. and Allsopp, M.N.E. (1972) Prophylactic lithium in recurrent affective disorders. Lancet, i, 1044–6.CrossRefGoogle Scholar
  23. Jerram, T.C. and McDonald, R. (1978) Plasma lithium control with particular reference to minimum effective levels. In: Lithium in Medical Practice (eds. F.N. Johnson and S. Johnson), MTP Press, Lancaster, pp. 407–13.Google Scholar
  24. Kantor, S.J. and Glassman, A.H. (1980) In: Psychopharmacology of Ageing (eds. C. Eisdorfer and W.E. Fann), MTP Press, Lancaster, pp. 99–117.CrossRefGoogle Scholar
  25. Mindham, R.H.S., Howland, C. and Shepherd, M. (1973) An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychological Medicine, 3, 5–17.CrossRefPubMedGoogle Scholar
  26. Murphy, E. (1983) The prognosis of depression in old age. Br. J. Psychiat., 142, 111–13.CrossRefGoogle Scholar
  27. Perry, P.J. and Tsuang, M.T. (1979) Treatment of unipolar depression following electroconvulsive therapy: relapse rate comparisons between lithium and tricyclic therapies following ECT. J. Affect. Disord., 1, 123–9.CrossRefPubMedGoogle Scholar
  28. Prien, R.F., Klett, C.J. and Caffey, E.M. (1973) Lithium carbonate and Imipramine prevention of affective psychoses. Arch. Gen. Psychiat., 29, 303–13.CrossRefGoogle Scholar
  29. Quitkin, F., Rifkin, A. and Kane, J. (1978) Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. Am. J. Psychiat., 133, 570–2.Google Scholar
  30. Sashidhoran, B., McGuire, R.J. and Glen, A.I.M. (1982) Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study. Br. J. Psychiat., 140, 619–22.CrossRefGoogle Scholar
  31. Thompson, T.L., Moran, M.G. and Nies, A.S. (1983) Psychotropic drug use in the elderly (parts 1 and 2). N. Eng. J. Med., 308, 134–8; 194–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1989

Authors and Affiliations

  • Karabi Ghose
  • Alec Coppen

There are no affiliations available

Personalised recommendations